|
1
|
Harman SM, Metter EJ, Tobin JD, Pearson J
and Blackman MR: Longitudinal effects of aging on serum total and
free testosterone levels in healthy men. Baltimore Longitudinal
Study of Aging. J Clin Endocrinol Metab. 86:724–731. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
McNeal J: Pathology of benign prostatic
hyperplasia. Insight into etiology. Urol Clin North Am. 17:477–486.
1990.PubMed/NCBI
|
|
3
|
Untergasser G, Madersbacher S and Berger
P: Benign prostatic hyperplasia: Age-related tissue-remodeling. Exp
Gerontol. 40:121–128. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lucia MS and Lambert JR: Growth factors in
benign prostatic hyperplasia: Basic science implications. Curr Urol
Rep. 9:272–278. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sciarra A, Mariotti G, Salciccia S, Autran
Gomez A, Monti S, Toscano V and Di Silverio F: Prostate growth and
inflammation. J Steroid Biochem Mol Biol. 108:254–260. 2008.
View Article : Google Scholar
|
|
6
|
Von Der Mark K, Von Der Mark H and Goodman
S: Cellular responses to extracellular matrix. Kidney Int.
41:632–640. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Raghow R: The role of extracellular matrix
in postinflammatory wound healing and fibrosis. FASEB J. 8:823–831.
1994.PubMed/NCBI
|
|
8
|
Shu CX and Cheng TM: Structure and
function of extracellular matrix. Zhong Guo Xi Nan Guo Fang Yi Yao.
11:220–223. 2001.(In Chinese).
|
|
9
|
Cao W and Zhao AG: Prescription rules of
Chinese herbal medicines in treatment of gastric cancer. Zhong Xi
Yi Jie He Xue Bao. 7:1–8. 2009.(In Chinese). View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhou JH, Lin JM, Xu W, Zhong XY, Zheng YQ,
Hong ZF and Peng J: Qianliening capsule treats benign prostatic
hyperplasia through regulating the expression of sex hormones
estrogen receptor and androgen receptor. Afr J Pharm Pharmacol.
6:173–180. 2012. View Article : Google Scholar
|
|
11
|
Zhong XY, Lin JM, Zhou JH, Xu W, Hong ZF
and Peng J: Qianliening capsule treats benign prostatic hyperplasia
(BPH) by down-regulating the expression of PCNA, CyclinD1 and CDK4.
Afr J Biotechnol. 11:7731–7737. 2012.
|
|
12
|
Zhou JH, Lin JM, Xu W, Zhong XY, Zheng YQ,
Peng J, Xie JD and Hong ZF: Effects of Qianliening capsule on the
expression of IL-10 and TNF-α in benign prostate hyperplasia. Chin
Archives Trad Chin Med. 28:2657–2569. 2010.
|
|
13
|
Lin JM, Zhou JH, Zhong XY, Peng J, Xu W,
Zheng HY, Zhao JY and Hong ZF: Effects of Qianliening capsule on
the expression of EGF and EGFR in BPH Rats. Fujian J Trad Chin Med.
41:45–47. 2010.
|
|
14
|
Zheng HY, Xu W, Lin JM, Peng J and Hong
ZF: Qianliening capsule treats benign prostatic hyperplasia via
induction of prostatic cell apoptosis. Mol Med Rep. 7:848–854.
2013.PubMed/NCBI
|
|
15
|
Lin JM, Zhou JH, Xu W, Zhong XY, Hong ZF
and Peng J: Qianliening capsule treats benign prostatic hyperplasia
via suppression of the EGF/STAT3 signaling pathway. Exp Ther Med.
5:1293–1300. 2013.PubMed/NCBI
|
|
16
|
Li YM and Fang YH: Steroid hormones
binding sites and extracellular matrix in the tissue of human
benign prostatic hyperplasia. Chin J Urology. 15:269–271. 1994.
|
|
17
|
Li YM, Li YK, Hou SL, Fang SH, Li DQ and
Liu XX: Extracellular matrix and transforming growth factor-β in
the tissue of benign prostatic hyperplasia. Chin J Urology.
16:421–422. 1995.
|
|
18
|
Lubrano C, Petrangeli E, Catizone A,
Santonati A, Concolino G, Rombolá N, Frati L, Di Silverio F and
Sciarra F: Epidermal growth factor binding and steroid receptor
content in human benign prostatic hyperplasia. J Steroid Biochem.
34:499–504. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Roberts AB, McCune BK and Sporn MB: TGF-β:
Regulation of extrancellular matrix. Kidney Int. 41:577–559. 1992.
View Article : Google Scholar
|
|
20
|
Freeman MR, Song Y, Carson DD, Guthrie PD
and Chung LW: Extrancellular matrix and androgen receptor
expression associated with spontaneous transformation of rat
prostate fibroblast. Cancer Res. 51:1910–1916. 1991.PubMed/NCBI
|
|
21
|
Janković MM and Kosanović MM: Fibronectin
pattern in benign hyperplasia and cancer of the prostate. Dis
Markers. 25:49–58. 2008. View Article : Google Scholar
|
|
22
|
Djavan B, Lin V, Seitz C, Kramer G, Kaplan
P, Richier J, Marberger M and McConnell: Elastin gene expression in
benign prostatic hyperplasia. Prostate. 40:242–247. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Elliot SJ, Zorn BH, Mcleod DG, Moul JW,
Nyberg L, Striker LJ and Striker GE: Pentosan polysulfate decreases
prostate smooth muscle proliferation and extracellular matrix
turnover. Prostate Cancer Prostatic Dis. 6:138–142. 2003.
View Article : Google Scholar : PubMed/NCBI
|
